From the Guidelines
Ativan (lorazepam) use should be avoided for extended periods, especially in older adults, due to its association with an increased risk of dementia. The benzodiazepine class of medications, which includes Ativan, has been linked to a higher risk of developing dementia when used regularly for months or years 1. Key points to consider include:
- Short-term use (less than 2-4 weeks) appears to carry minimal risk
- Non-benzodiazepine alternatives like SSRIs for anxiety or non-pharmacological approaches such as cognitive behavioral therapy should be considered for treatment of anxiety or insomnia
- For those currently taking Ativan long-term, a gradual tapering schedule should be implemented to avoid withdrawal symptoms
- The connection between benzodiazepines and dementia likely involves these medications' effects on neurotransmitter systems and potential acceleration of neurodegenerative processes, which can impair memory formation and cognitive function even during regular use 2, 3. It is essential to weigh the benefits and risks of Ativan use, particularly in older adults, and to explore alternative treatment options to minimize the risk of dementia and other adverse effects.
From the Research
Ativan Use and Dementia Risk
- Ativan, a type of benzodiazepine, has been studied for its potential association with dementia risk 4, 5, 6.
- A meta-analysis of observational studies found that long-term benzodiazepine use significantly increases the risk of dementia in the elderly population, with a pooled rate ratio of 1.51 (95% CI=1.17-1.95, p=0.002) 4.
- Another study found that benzodiazepine use is associated with a higher risk of dementia, with an odds ratio of 1.78 (95% CI 1.33-2.38) 6.
- However, a systematic review of prospective longitudinal studies found little evidence of an association between long-term benzodiazepine use and cognitive decline, although the results were inconsistent and limited by methodological limitations 5.
Key Findings
- The risk of dementia is higher in patients taking benzodiazepines with a longer half-life (>20 hours) and for a longer duration (>3 years) 4.
- Global cognitive functioning, verbal memory, intelligence, psychomotor speed, and speed of processing are the cognitive domains affected by long-term benzodiazepine use 5.
- Other factors, such as diabetes, hypertension, cardiac disease, and statin drugs, are also associated with an increased risk of dementia 6.
Limitations
- The studies had significant statistical and clinical heterogeneity, which limits the ability to draw definitive conclusions 6.
- More research is needed to clarify whether the observed epidemiologic association between benzodiazepine use and dementia risk is a causal effect or the result of some unmeasured confounding variable 6.